BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30988278)

  • 1. Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells.
    Sui S; Zhang J; Xu S; Wang Q; Wang P; Pang D
    Cell Death Dis; 2019 Apr; 10(5):331. PubMed ID: 30988278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BET bromodomain inhibitor, JQ1, facilitates c-FLIP degradation and enhances TRAIL-induced apoptosis independent of BRD4 and c-Myc inhibition.
    Yao W; Yue P; Khuri FR; Sun SY
    Oncotarget; 2015 Oct; 6(33):34669-79. PubMed ID: 26415225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRD4 promotes metastatic potential in oral squamous cell carcinoma through the epigenetic regulation of the MMP2 gene.
    Yamamoto T; Hirosue A; Nakamoto M; Yoshida R; Sakata J; Matsuoka Y; Kawahara K; Nagao Y; Nagata M; Takahashi N; Hiraki A; Shinohara M; Nakao M; Saitoh N; Nakayama H
    Br J Cancer; 2020 Aug; 123(4):580-590. PubMed ID: 32499570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of BDNF Expression and Memory by HDAC Inhibition Requires BET Bromodomain Reader Proteins.
    Sartor GC; Malvezzi AM; Kumar A; Andrade NS; Wiedner HJ; Vilca SJ; Janczura KJ; Bagheri A; Al-Ali H; Powell SK; Brown PT; Volmar CH; Foster TC; Zeier Z; Wahlestedt C
    J Neurosci; 2019 Jan; 39(4):612-626. PubMed ID: 30504275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromodomain Protein BRD4 Is a Transcriptional Repressor of Autophagy and Lysosomal Function.
    Sakamaki JI; Wilkinson S; Hahn M; Tasdemir N; O'Prey J; Clark W; Hedley A; Nixon C; Long JS; New M; Van Acker T; Tooze SA; Lowe SW; Dikic I; Ryan KM
    Mol Cell; 2017 May; 66(4):517-532.e9. PubMed ID: 28525743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brd4 is essential for IL-1β-induced inflammation in human airway epithelial cells.
    Khan YM; Kirkham P; Barnes PJ; Adcock IM
    PLoS One; 2014; 9(4):e95051. PubMed ID: 24759736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromodomain and extraterminal inhibition blocks tumor progression and promotes differentiation in neuroblastoma.
    Lee S; Rellinger EJ; Kim KW; Craig BT; Romain CV; Qiao J; Chung DH
    Surgery; 2015 Sep; 158(3):819-26. PubMed ID: 26067464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer.
    Ghoochani A; Hsu EC; Aslan M; Rice MA; Nguyen HM; Brooks JD; Corey E; Paulmurugan R; Stoyanova T
    Cancer Res; 2021 Mar; 81(6):1583-1594. PubMed ID: 33483372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BET inhibitor nanotherapy halts kidney damage and reduces chronic kidney disease progression after ischemia-reperfusion injury.
    Saiz ML; Lozano-Chamizo L; Florez AB; Marciello M; Diaz-Bulnes P; Corte-Iglesias V; Bernet CR; Rodrigues-Diez RR; Martin-Martin C; Rodriguez-Santamaria M; Fernandez-Vega I; Rodriguez RM; Diaz-Corte C; Suarez-Alvarez B; Filice M; Lopez-Larrea C
    Biomed Pharmacother; 2024 May; 174():116492. PubMed ID: 38537579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial pyruvate carrier 1 regulates ferroptosis in drug-tolerant persister head and neck cancer cells via epithelial-mesenchymal transition.
    You JH; Lee J; Roh JL
    Cancer Lett; 2021 Jun; 507():40-54. PubMed ID: 33741422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV.
    Niu Q; Liu Z; Alamer E; Fan X; Chen H; Endsley J; Gelman BB; Tian B; Kim JH; Michael NL; Robb ML; Ananworanich J; Zhou J; Hu H
    J Clin Invest; 2019 Jul; 129(8):3361-3373. PubMed ID: 31329163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astaxanthin Synergizes with Ionizing Radiation (IR) in Oral Squamous Cell Carcinoma (OSCC).
    Du Y; Shuai Y; Liu Z; Li H; Yin Y
    Mol Biotechnol; 2024 May; 66(5):1220-1228. PubMed ID: 38103098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer.
    Yang J; Zhou Y; Xie S; Wang J; Li Z; Chen L; Mao M; Chen C; Huang A; Chen Y; Zhang X; Khan NUH; Wang L; Zhou J
    J Exp Clin Cancer Res; 2021 Jun; 40(1):206. PubMed ID: 34162423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Lapachone induces ferroptosis of colorectal cancer cells via NCOA4-mediated ferritinophagy by activating JNK pathway.
    Zhao L; Miao H; Quan M; Wang S; Zhang Y; Zhou H; Zhang X; Lin Z; Piao J
    Chem Biol Interact; 2024 Feb; 389():110866. PubMed ID: 38218311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer.
    Zhu X; Fu Z; Dutchak K; Arabzadeh A; Milette S; Steinberger J; Morin G; Monast A; Pilon V; Kong T; Adams BN; Prando Munhoz E; Hosein HJB; Fang T; Su J; Xue Y; Rayes R; Sangwan V; Walsh LA; Chen G; Quail DF; Spicer JD; Park M; Dankort D; Huang S
    Cancer Res; 2024 Apr; 84(8):1333-1351. PubMed ID: 38277141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YIQIFUMAI INJECTION AMELIORATED SEPSIS-INDUCED CARDIOMYOPATHY BY INHIBITION OF FERROPTOSIS VIA XCT/GPX4 AXIS.
    Guo L; Li P; Wang Y; Wang J; Lei J; Zhao J; Wu X; He W; Jia J; Miao J; Wang D; Cui H
    Shock; 2024 Apr; 61(4):638-645. PubMed ID: 37983962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding Mechanism of Inhibitors to BRD4 and BRD9 Decoded by Multiple Independent Molecular Dynamics Simulations and Deep Learning.
    Wang J; Yang W; Zhao L; Wei B; Chen J
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic body-inspired nanotherapeutics efficiently attenuate osteoarthritis by targeting BRD4-regulated synovial macrophage polarization.
    Xu YD; Liang XC; Li ZP; Wu ZS; Yang J; Jia SZ; Peng R; Li ZY; Wang XH; Luo FJ; Chen JJ; Cheng WX; Zhang P; Zha ZG; Zeng R; Zhang HT
    Biomaterials; 2024 Apr; 306():122483. PubMed ID: 38330742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRD4 inhibitors broadly promote erastin-induced ferroptosis in different cell lines by targeting ROS and FSP1.
    Fan C; Guo X; Zhang J; Zheng W; Shi C; Qin Y; Shen H; Lu Y; Fan Y; Li Y; Chen L; Mao R
    Discov Oncol; 2024 Apr; 15(1):98. PubMed ID: 38565708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin.
    Yang C; Zhang Y; Lin S; Liu Y; Li W
    Aging (Albany NY); 2021 Mar; 13(10):13515-13534. PubMed ID: 33819186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.